140 related articles for article (PubMed ID: 2183712)
1. Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.
Ikeda Y; Fukuoka Y; Motomura K; Yasuda T; Nishino T
Antimicrob Agents Chemother; 1990 Jan; 34(1):94-7. PubMed ID: 2183712
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
Ikeda Y; Nishino T; Tanino T
Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
Ikeda Y; Nishino T
Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
Okonogi K; Kuno M; Kida M; Mitsuhashi S
Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
[TBL] [Abstract][Full Text] [Related]
5. Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
Minami S; Araki H; Watanabe Y; Yasuda T; Takai A; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Feb; 29(2):376-8. PubMed ID: 3521482
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
Yang YJ; Livermore DM
Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and beta-lactamase stability of cefmenoxime.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial profiling and molecular characterization of antibiotic resistant genes of Proteus vulgaris isolated from tertiary care hospital, Islamabad, Pakistan.
Bilal S; Anam S; Mahmood T; Abdullah RM; Nisar S; Kalsoom F; Luqman M; Anjum FR
Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2887-2891. PubMed ID: 32024629
[TBL] [Abstract][Full Text] [Related]
9. The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Gomez-Alferez A; Baquero F; Canton R; Loza E; Martinez-Beltran J
J Chemother; 1991 Oct; 3(5):283-8. PubMed ID: 1809807
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
Dalhoff A; Gehl AE; Gau W; Lode H
Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
[TBL] [Abstract][Full Text] [Related]
11. Induction of beta-lactamase in Proteus vulgaris.
Okonogi K; Kuno M; Higashide E
J Gen Microbiol; 1986 Jan; 132(1):143-50. PubMed ID: 3519851
[TBL] [Abstract][Full Text] [Related]
12. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
[TBL] [Abstract][Full Text] [Related]
13. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris.
Yotsuji A; Minami S; Araki Y; Inoue M; Mitsuhashi S
J Antibiot (Tokyo); 1982 Nov; 35(11):1590-3. PubMed ID: 6761329
[No Abstract] [Full Text] [Related]
14. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
Dalhoff A; Gehl AE; Lode H
Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
16. Behaviour of cefmenoxime towards beta-lactamases.
Labia R; Morand A; Ben Yaghlane H; Bryskier A
Drugs Exp Clin Res; 1985; 11(6):373-8. PubMed ID: 3939122
[TBL] [Abstract][Full Text] [Related]
17. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Campoli-Richards DM; Todd PA
Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
[TBL] [Abstract][Full Text] [Related]
18. Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.
Ohno A; Ishii Y; Ma L; Yamaguchi K
J Clin Microbiol; 2000 Feb; 38(2):677-81. PubMed ID: 10655366
[TBL] [Abstract][Full Text] [Related]
19. Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A.
Péduzzi J; Reynaud A; Baron P; Barthélémy M; Labia R
Biochim Biophys Acta; 1994 Jul; 1207(1):31-9. PubMed ID: 8043607
[TBL] [Abstract][Full Text] [Related]
20. [Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].
Rodríguez C; Radice M; Perazzi B; Castro S; Juárez J; Santini P; Vay C; Famiglietti A; Gutkind G
Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):122-6. PubMed ID: 15757582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
